HDAC9 and pulmonary fibrosis: Zolinza®, also known as Suberoylanilide hydroxamic acid (SAHA, a HDAC inhibitor), has been proved to have anti-fibrotic effect in both bleomycin-induced pulmonary fibrosis and chlorhexidine gluconate-induced peritoneal fibrosis in mice [9, 10].